> top > docs > PMC:7195088 > spans > 22875-25323 > annotations

PMC:7195088 / 22875-25323 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
680 142-150 Species denotes patients Tax:9606
681 193-201 Species denotes patients Tax:9606
682 275-283 Species denotes patients Tax:9606
813 0-11 Chemical denotes Favipiravir MESH:C462182
814 164-175 Chemical denotes favipiravir MESH:C462182
815 212-222 Chemical denotes umifenovir MESH:C086979
816 294-305 Chemical denotes favipiravir MESH:C462182
947 133-141 Disease denotes COVID-19 MESH:C000657245
948 184-192 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T20 27-30 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T21 41-44 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T22 1652-1658 Body_part denotes sputum http://purl.org/sig/ont/fma/fma312401

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T19 1652-1658 Body_part denotes sputum http://purl.obolibrary.org/obo/UBERON_0007311

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T111 17-26 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T112 133-141 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 184-192 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T114 473-481 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T115 687-695 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T116 974-982 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T117 1052-1060 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T118 1201-1209 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T119 1461-1469 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T120 1753-1761 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T121 2034-2042 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T122 2321-2329 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T123 2399-2407 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T112 71-72 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T113 97-98 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T114 360-364 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T115 360-364 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T116 488-493 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T117 989-994 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T118 1216-1221 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T119 1318-1319 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T120 1535-1536 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T121 1627-1628 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T122 1768-1773 http://purl.obolibrary.org/obo/CLO_0007225 denotes label
T123 1850-1854 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T124 2336-2341 http://purl.obolibrary.org/obo/CLO_0007225 denotes label

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T270 41-65 Chemical denotes RNA polymerase inhibitor http://purl.obolibrary.org/obo/CHEBI_37416
T271 56-65 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T272 164-175 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T273 212-222 Chemical denotes umifenovir http://purl.obolibrary.org/obo/CHEBI_134730
T274 294-305 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T275 395-406 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T276 411-422 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T277 427-438 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T278 444-455 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T279 488-493 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T280 595-606 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T281 612-623 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T282 628-639 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T283 645-664 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T284 645-654 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T285 655-664 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T286 703-722 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T287 703-712 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T288 713-722 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T289 728-739 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T290 744-753 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T291 754-763 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T292 769-780 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T293 785-796 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T294 802-821 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T295 802-811 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T296 812-821 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T297 826-835 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T298 836-845 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T299 851-862 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T300 868-879 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T301 884-893 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T302 894-903 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T303 909-920 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T304 926-937 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T305 989-994 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T306 1118-1136 Chemical denotes hydroxychloroquine http://purl.obolibrary.org/obo/CHEBI_5801
T307 1142-1151 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T308 1152-1162 Chemical denotes cobicistat http://purl.obolibrary.org/obo/CHEBI_72291
T309 1216-1221 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T310 1387-1398 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T311 1404-1415 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T312 1420-1431 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T313 1703-1714 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T314 1768-1773 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209
T315 1837-1849 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T316 1845-1849 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T317 1942-1953 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T318 1959-1970 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T319 1975-1986 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T320 1992-2011 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T321 1992-2001 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T322 2002-2011 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T323 2050-2069 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T324 2050-2059 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T325 2060-2069 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T326 2075-2086 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T327 2091-2100 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T328 2101-2110 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T329 2116-2127 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T330 2132-2143 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T331 2149-2168 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T332 2149-2158 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T333 2159-2168 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T334 2173-2182 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T335 2183-2192 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T336 2198-2209 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T337 2215-2226 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T338 2231-2240 Chemical denotes darunavir http://purl.obolibrary.org/obo/CHEBI_367163
T339 2241-2250 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T340 2256-2267 Chemical denotes favipiravir http://purl.obolibrary.org/obo/CHEBI_134722
T341 2273-2284 Chemical denotes oseltamivir http://purl.obolibrary.org/obo/CHEBI_7798
T342 2336-2341 Chemical denotes label http://purl.obolibrary.org/obo/CHEBI_35209

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T170 0-306 Sentence denotes Favipiravir Anti-influenza RNA-dependent RNA polymerase inhibitor • In a recent RCT published on a preprint server and comparing 120 COVID-19 patients treated with favipiravir vs. 120 COVID-19 patients receiving umifenovir, higher rates of clinical recovery were observed in patients receiving favipiravir.
T171 307-482 Sentence denotes The manuscript is publicly available but still to be peer reviewed [30] • Comparison of favipiravir vs. tocilizumab vs. favipiravir plus tocilizumab in patients with COVID-19.
T172 483-524 Sentence denotes Open-label RCT (NCT04310228, recruiting).
T173 525-578 Sentence denotes Primary endpoint: clinical cure (follow-up 3 months).
T174 579-983 Sentence denotes • Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ritonavir plus oseltamivir vs. favipiravir plus lopinavir/ritonavir vs. darunavir/ritonavir plus oseltamivir plus chloroquine vs. darunavir/ritonavir plus favipiravir plus oseltamivir in patients with moderate to severe COVID-19.
T175 984-1033 Sentence denotes Open-label RCT (NCT04303299, not yet recruiting).
T176 1034-1101 Sentence denotes Primary endpoint: SARS-CoV-2 eradication time (follow-up 24 weeks).
T177 1102-1210 Sentence denotes • Comparison of hydroxychloroquine plus darunavir/cobicistat vs. standard of care in patients with COVID-19.
T178 1211-1252 Sentence denotes Open-label RCT (NCT04304053, recruiting).
T179 1253-1370 Sentence denotes Primary endpoint: incidence of secondary cases among contacts of a case and contacts of contacts (follow-up 14 days).
T180 1371-1470 Sentence denotes • Comparison of chloroquine plus favipiravir vs. favipiravir vs. placebo in patients with COVID-19.
T181 1471-1514 Sentence denotes Double-blind RCT (NCT04319900, recruiting).
T182 1515-1686 Sentence denotes Primary endpoints: (a) time to improvement/recovery and frequency of improvement/recovery (follow-up 10 days); (b) time to negative swab/sputum RT-PCR (follow-up 10 days).
T183 1687-1762 Sentence denotes • Comparison of favipiravir vs. standard of care in patients with COVID-19.
T184 1763-1812 Sentence denotes Open-label RCT (NCT04333589, not yet recruiting).
T185 1813-1925 Sentence denotes Primary endpoint: viral nucleic acid test negative conversion rate in nasopharyngeal swabs (follow-up 5 months).
T186 1926-2330 Sentence denotes • Comparison of oseltamivir plus chloroquine vs. oseltamivir plus lopinavir/ritonavir in patients with mild COVID-19 and of lopinavir/ritonavir plus oseltamivir vs. darunavir/ritonavir plus oseltamivir vs. favipiravir plus lopinavir/ritonavir vs. darunavir/ritonavir plus oseltamivir plus chloroquine vs. darunavir/ritonavir plus favipiravir plus oseltamivir in patients with moderate to severe COVID-19.
T187 2331-2380 Sentence denotes Open-label RCT (NCT04303299, not yet recruiting).
T188 2381-2448 Sentence denotes Primary endpoint: SARS-CoV-2 eradication time (follow-up 24 weeks).